Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 30, 2010 (rev. 1)


Predictive Biosciences this week appointed Thomas Ross as chief commercial officer and Randal Vader as vice president of clinical and regulatory affairs.

Ross most recently served as vice president of North American molecular diagnostic sales at Qiagen. Prior to that, he worked for Digene (now part of Qiagen), where he was responsible for driving expansion of physician and laboratory sales, Predictive said.

Vader most recently was senior vice president of quality, regulatory, and clinical affairs at Orthofix. Prior to that, he worked for EraGen Biosciences, where he helped obtain US Food and Drug Administration clearance for Eragen's herpes simplex virus molecular diagnostic test.

UK-based molecular diagnostics company Biofortuna said this week that it recently named David Whitcombe as non-executive director.

Whitcombe was previously a co-founder of DxS, which Qiagen acquired last year.

The Scan

Test of the China Initiative

According to Science, the upcoming trial of Harvard University chemist Charles Lieber will test the US China Initiative.

Collaborative Approach

A virologist who spotted the Omicron variant of SARS-CoV-2 tells the Associated Press that its detection was aided by scientific sharing.

Genes of a Guide Dog

Wired reports on a study aimed at uncovering genes involved in being a successful guide dog.

PLOS Papers on RNAs in Metastatic Prostate Cancer, Ebola Field Lab, Embryonic RNA Editing

In PLOS this week: circRNA-mediated ceRNA network points to prostate cancer biomarkers, Ebola testing at frontline field laboratory, and more.